Search Contract Opportunities

Notice of Intent to Award a Sole Source Commercial Simplified Acquisition Procedures (SAP) Purchase Order for Supply Chain Monitoring – Infant Formula

ID: HFP-2026-134162 • Type: Special Notice • Match:  85%
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Please sign-in to link federal registration and award history to assistant. Sign in to upload a capability statement or catalogue for your company

Popular Questions:
Generate a draft:
Loading

Description

The Food and Drug Administration (FDA) intends to award a Sole Source firm-fixed-price commercial service contract to Circana, LLC (Circana), 203 North LaSalle Street, Suite 1500, Chicago, IL, 60601, USA, for the Purchase of Supply Chain Monitoring Infant Formula in accordance with the authority under FAR RFO Part 6.103-1 , Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements.
Circana is the only known source capable of obtain critical data needed to monitor the availability of infant formula products in the United States to support continuity of the FDA's monitoring the infant formula supply chain - U.S. infant formula shortage initiative. No other sources have expressed an interest in writing in the proposed acquisition.

This acquisition is being conducted using simplified acquisition procedures in accordance with FAR RFO Part 12 for the acquisition of commercial products and commercial services.

The North American Industry Classification System (NAICS) code for the proposed acquisition is 541910 - Marketing Research and Public Opinion Polling $22.5.

Deliverables:

CLIN 1 - Out of Stock Tracking Solution (OOS) - 2 user licenses Estimated Delivery Date 07/30/2026 (Valid 1 Year)

CLIN 2 - Liquid Data Go (LDG) - 1 user license - Estimated Delivery Date 07/30/2026 (Valid 1 Year)
Responses

Responses to this notice should be sent to Haroon Gulzar at haroon.gulzar@fda.hhs.gov no later than 5:00 pm (ET) on July 10, 2026. This notice is not a request for competitive quotes. Any other firms desiring consideration must fully identify their interest and capability of meeting the requirements by submitting a capability statement. Any response shall undergo review to determine if it can meet the requirements. A determination by the Government not to compete this proposed requirement based upon a response to this notice is solely within the discretion of the Government.

Overview

Response Deadline
May 10, 2026, 5:00 p.m. EDT Past Due
Posted
July 5, 2026, 12:53 p.m. EDT
Set Aside
None
Place of Performance
Chicago, IL United States
Source

Current SBA Size Standard
$22.5 Million
Pricing
Fixed Price
Est. Level of Competition
Sole Source
On 7/5/26 Food and Drug Administration issued Special Notice HFP-2026-134162 for Notice of Intent to Award a Sole Source Commercial Simplified Acquisition Procedures (SAP) Purchase Order for Supply Chain Monitoring – Infant Formula due 5/10/26.
Primary Contact
Name
Haroon Gulzar
Phone
None

Secondary Contact

Name
Craig Wright   Profile
Phone
None

Documents

Posted documents for Special Notice HFP-2026-134162

Opportunity Assistant


AI Analysis

AI Generate

Incumbent or Similar Awards

Potential Bidders and Partners

Awardees that have won contracts similar to Special Notice HFP-2026-134162

Similar Active Opportunities

Open contract opportunities similar to Special Notice HFP-2026-134162

Experts for Notice of Intent to Award a Sole Source Commercial Simplified Acquisition Procedures (SAP) Purchase Order for Supply Chain Monitoring – Infant Formula

Recommended subject matter experts available for hire

Additional Details

Source Agency Hierarchy
HEALTH AND HUMAN SERVICES, DEPARTMENT OF > FOOD AND DRUG ADMINISTRATION > FDA OFFICE OF ACQ GRANT SVCS
FPDS Organization Code
7524-00223
Source Organization Code
100188033
Last Updated
July 5, 2026
Last Updated By
craig.wright@fda.hhs.gov
Archive Date
May 25, 2026